TPI
TrumpEconomyImmigrationCrimeCongressHealthcareCourts
Subscribe
TPI
The Political Insider
thepoliticalinsider.com|Privacy Policy|Contact|© 2026 The Publisher Desk

Trump Orders FDA to Review Psychedelic Breakthrough Drugs

April 18, 2026·20 days ago·via Fox News
Trump Orders FDA to Review Psychedelic Breakthrough Drugs
President Trump signs an executive order directing the FDA to review psychedelics designated as breakthrough therapy drugs, cutting through bureaucratic red tape to unlock potential treatments. This bold move prioritizes American innovation and patient access over globalist regulatory shackles that have stalled progress for too long. Trump proves once again he's fighting for real solutions, not endless government delays. Read more about this...

Related Coverage

WebsiteTrump signs executive order directing FDA to review psychedelics designated as breakthrough therapy drugs — Fox News Politics
WebsiteTrump Cuts Wait For Breakthrough Mental Health Treatments For Veterans — Daily Wire
SubstackUK mid-term elections — Power Line
WebsiteRED FLAG: FBI says these apps let China suck up your personal data — The Blaze
WebsiteWe keep talking about Jesus. We refuse to define Him. — The Blaze
WebsiteJoe Rogan Joins Trump for Signing of EO to Fast-Track Access to Psychedelic Drug-Based Research, Treatment — Breitbart
WebsiteTrump Orders Expansion of Psychedelic Drug Trials — Joe Rogan Attends Signing Ceremony (VIDEO) — The Gateway Pundit